AXA (AXAHY: OTCQX International Premier) | OTC Markets

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
AXA (AXAHY: OTCQX International Premier) | OTC Markets Group Announces Second Quarter Performance of OTCM ADR Index and OTCQX ADR 30 Index OTC Markets Group Announces Second Quarter Performance of OTCM ADR Index and OTCQX ADR 30 Index

OTC Markets Group Announces Second Quarter Performance of OTCM ADR Index and OTCQX ADR 30 Index

PR Newswire

NEW YORK , July 17, 2014 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM) today announced the second quarter 2014 performance of the OTCM ADR Index (Bloomberg/Reuters: OTCDR; Thomson: DFCDR) and the OTCQX ADR 30 Index (Bloomberg/Reuters: OTCQX30; Thomson: DGCQX), powered by BNY Mellon DR Indices SM . 

(Logo: http://photos.prnewswire.com/prnh/20110118/MM31963LOGO )

The OTCM ADR Index, the only index exclusively tracking American Depositary Receipts ("ADRs") on the OTCQX®, OTCQB® and OTC Pink® marketplaces, rose 4.23% in the second quarter, reversing a 0.13% decline in the first quarter. The index was up 4.1% year-to-date. 

The OTCQX ADR 30 Index, which launched on April 9 , increased 3.43% in the second quarter.  The index is comprised of the 30 largest ADRs on the OTCQX marketplace which has high financial standards, reporting requirements and third-party sponsorship.  Components of the OTCQX ADR 30 Index include well-known global companies such as Adidas AG (OTCQX: ADDYY), AXA (OTCQX: AXAHY), British Sky Broadcasting Group Plc (OTCQX: BSYBY), Danone (OTCQX: DANOY) and Roche Holding Ltd. (OTCQX: RHHBY).

"We are pleased with the positive return of the OTCQX ADR 30 Index in the second quarter," said R. Cromwell Coulson , President and CEO of OTC Markets Group.  "OTCQX ADRs are the most established, transparent and shareholder-friendly global companies trading on our marketplaces and represent a tremendous opportunity for U.S. investors looking to safely and confidently diversify their global portfolios. We anticipate launching more new indices later this year."  

Second Quarter 2014 Highlights:

  • The OTCM ADR Index rose 4.23% in the second quarter and was up 4.1% year-to-date through June 30 , 2014.  The more than 600 ADRs within the index traded $30 billion in the second quarter, slightly down from the $33.86 billion traded in the first quarter but above the prior year quarter of $26 billion .
  • The best-performing component industries during the quarter were oil and gas (+11%), technology (+7.54%) and utilities (+6.98%). 
  • Sixty-three new companies were added to the OTCM ADR Index during the second quarter, including Nighthawk Energy Plc (OTCQX: NHEGY), OCI N.V. (OTCQX: OCINY), Siemens AG (OTC Pink: SIEGY) and Technicolor (OTCQX: TCLRY).  Forty-four companies were removed from the index during the quarter.
  • The OTCQX ADR 30 Index rose 3.43% in the second quarter.  OTCQX ADRs within the index traded $6.4 billion during the quarter. 

The OTCM ADR Index and OTCQX ADR 30 Index are rules-based indices that are market capitalization weighted, adjusted for free float, and have various liquidity screens to ensure tradability.  Both indices are priced in real-time and disseminated on all major financial platforms. 

For a current list of all OTCM ADR Index and OTCQX ADR 30 Index constituents as well as real-time quotes, charts and data, visit the OTC Markets Group website, www.otcmarkets.com .

Past performance does not guarantee future results.  Investors cannot invest directly in the OTCM ADR Index or OTCQX ADR 30 Index.

About BNY Mellon DR Indices

BNY Mellon's DR Index team provides more than 140 indices, and there are now 17 ETFs trading in the U.S., Canada and Korea using BNY Mellon indices as their primary benchmarks.  To learn more about BNY Mellon's DR Indices, visit www.bnymellondrindex.com .

BNY Mellon acts as depositary for more than 2,700 American and global depositary receipt programs, acting in partnership with leading companies from 68 countries.  BNY Mellon is committed to helping securities issuers access the world's rapidly evolving financial markets and delivers a comprehensive suite of depositary receipt services.  Learn more at www.bnymellon.com/dr

About OTC Markets Group Inc.

OTC Markets Group Inc. (OTCQX: OTCM) operates Open, Transparent and Connected financial marketplaces for 10,000 U.S. and global securities. Through our OTC Link® ATS, we directly link a diverse network of broker-dealers that provide liquidity and execution services for a wide spectrum of securities. We organize these securities into marketplaces to better inform investors of opportunities and risks – OTCQX®, The Best Marketplace; OTCQB®, The Venture Stage Marketplace; and OTC Pink®, The Open Marketplace. Our data-driven platform enables investors to easily trade through the broker of their choice at the best possible price and empowers a broad range of companies to improve the quality and availability of information for their investors. To learn more about how we create better informed and more efficient financial marketplaces, visit www.otcmarkets.com .

OTC Link ATS is operated by OTC Link LLC, member FINRA/SIPC and SEC regulated ATS.

Subscribe to the OTC Markets Group RSS Feed

 

SOURCE OTC Markets Group Inc.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

What to Expect: Your First Therapy Session Insights

Updated Category News Views 169

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 337

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
TORRAS Stands Tall with iPhone 18 Pro Cases

Updated Category News Views 191

TORRAS Shines in Magnetic Stand Case Evaluation In the whirlwind of smartphone accessories, where the battle lines are drawn between protection and functionality, TORRAS has emerged victorious with its magnetic stand cases for the iPhone 18 Pro and its beefier brother, the iPhone 18 Pro Max. Expert Consumers—a trusted name in product evaluations—has given TORRAS the...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 143

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 154

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 352

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 134

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 0

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 37

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 163

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Stock Market News: Nasdaq Dips as Applied Materials Shines

Updated Category News Views 191

Stock Market Declines on Nasdaq Today, U.S. stocks faced challenges with the Nasdaq Composite dropping significantly. The market opened lower with declines across major indices, signaling a cautious trading atmosphere. Market Overview As the day progressed, the Dow Jones Industrial Average fell by 1.21% to 46,882.86, while the NASDAQ retreated by 1.51%, settling at...

Continue Reading
Fastly Eyewitness: A Look at Recent Stock Performance

Updated Category News Views 205

Fastly's Impressive Stock Surge Fastly stock has recently shown remarkable movement, trading at near recent highs, indicating strong investor confidence in the company. The notable increase has left many wondering how long this momentum can be sustained. AI Transformation Sparks Interest Shifting Perspectives in Technology The recent ascent of Fastly's stock is largely...

Continue Reading
Exploring the Transformation of Social Media Management Market

Updated Category News Views 139

Understanding the Evolution of the Social Media Management Market The social media management market is experiencing remarkable growth. From a value of $17.5 billion in 2022, projections indicate it may reach $51.8 billion by 2027. This surge represents a compound annual growth rate (CAGR) of 24.2%. Companies worldwide are adapting to the increasing reliance on social...

Continue Reading
WestBond Enterprises Posts Year-End Financial Results and Outlook

Updated Category News Views 166

WestBond Enterprises Financial Overview WestBond Enterprises Corporation (TSX-V: WBE), a notable player in the manufacturing sector, has reported a financial loss of $52,380 for the year ending in March, reflecting a notable decrease from the previous year's loss of $210,683. Despite the loss, the company experienced a 4.9% increase in sales, which totaled $9,673,002,...

Continue Reading
Investors of Ultra Clean Urged to Act Amidst Stock Decline

Updated Category News Views 239

Investigation by Faruqi & Faruqi for Ultra Clean Investors Faruqi & Faruqi, LLP, a prominent national securities law firm, is reaching out to investors who have experienced losses exceeding $50,000 in Ultra Clean Holdings, Inc. (NASDAQ: UCTT). The firm aims to discuss potential legal options available to these investors following troubling financial disclosures from Ultra...

Continue Reading